Translational Development

Arsenal Medical

Matthew Boyd and Brian Johnson are joined by Upma Sharma and Carmichael Roberts from Arsenal Medical

×

Please feel out the form below and someone from our team will contact you shortly.

Duration: 79:50 Recorded August 2023

Guests

  • Upma Sharma President & CEO, Arsenal Medical
  • Carmichael Roberts Managing Partner, Material Impact

Transcript

On Point video shorts from the episode

Biomaterials as Devices

Commercializing biomaterials as medical devices

Evolution of Biomaterials

The next evolution of biomedical devices from metal to plastic to biomaterials

Biochemical and Structural

Biomedical applications that require both biochemical and structural solutions

Funding Innovation

Funding biomedical innovation through the commercial stages

Investing Advice

Investing in what you know

NeoCast

Commercial status of Arsenal's NeoCast product

Government Funding

Challenges and benefits of attracting sources of government funding

Reimbursement Hurdles

Reimbursement for a novel breakthrough device

Biomaterials Platform

A biomaterials platform company

Great Communication

Communication during commercialization for a novel biomedical innovation

Founder or Entrepreneur

The difference between a founder and an entrepreneur
RP-DI-006_translational-development_cover_2550x3300
Part of the Study

Translational Development

Why promising research stalls on the way to patients and how researchers become entrepreneurs by protecting IP, proving commercial viability, raising funds and building the right team

Additional Reading

Content Card - Just Mighty - Boyd - Two Color - Full (1920 x 1080)
Logo - Just Mighty - White Logo (400 x 400)

Your innovation Just Might change the world. But the odds are against you. We help you turn Just Might into Just Mighty.